NEW YORK, NY / ACCESSWIRE / December 5, 2022 / Kehoe Law Firm, P.C. is investigating whether the directors and/or officers of Fulgent Genetics, Inc. ("Fulgent") (NASDAQ: FLGT) breached their fiduciary duties to Fulgent and its shareholders.
The investigation concerns whether certain Fulgent directors and/or officers breached their fiduciary duties to Fulgent and its shareholders by making, or causing Fulgent to make, false and/or misleading statements, in addition to failing to disclose material adverse facts, about Fulgent's business, operations, prospects, and financial health.
INVESTORS OF FULGENT GENETICS SINCE AT LEAST AUGUST 4, 2022 ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS OF THEIR FULGENT SECURITIES.
SHAREHOLDERS OF FULGENT GENETICS STOCK SINCE AT LEAST AUGUST 4, 2022 ARE ALSO ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE INVESTIGATION AND FOR A FREE, NO-OBLIGATION EVALUATION OF POTENTIAL LEGAL CLAIMS.
Kehoe Law Firm, P.C., with offices in New York and Philadelphia, is a multidisciplinary, plaintiff-side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct. Combined, the partners at Kehoe Law Firm, P.C. have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.
This press release may constitute attorney advertising.
SOURCE: Kehoe Law Firm, P.C.